在乳腺癌中,MTCH2通过PI3K/Akt通路刺激细胞增殖和循环
Wenying Jiang1,2, Yuxia Miao3, Xiaoxiao Xing4
1Department of Radiology, The Third Affiliated Hospital of Soochow University, Changzhou, 213000, China.
Heliyon
|April 1, 2024
概括
线粒体蛋白MTCH2在乳腺癌 (BC) 中被上调,促进细胞增殖和进展. 沉默MTCH2通过影响PI3K/Akt通路来抑制BC生长,提供潜在的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体外膜蛋白MTCH2调节细胞死亡.
- 目前尚不清楚MTCH2在乳腺癌 (BC) 病理生理学中的作用.
研究的目的:
- 研究MTCH2在乳腺癌中的作用.
- 阐明MTCH2影响BC增殖和细胞周期进展的机制.
主要方法:
- 在BC中对MTCH2表达的生物信息分析.
- 在体外研究中使用具有MTCH2过度表达和淘汰的细胞系.
- 在体内异种移植模型.
- 对PI3K/Akt和IGF-1R信号通路的分析.
主要成果:
- 在BC中,MTCH2的表达上调,与患者的存活率相关.
- 过度表达MTCH2可以增强BC细胞的增殖和循环的进展.
- 沉默MTCH2抑制了增殖,并诱导细胞循环停止.
- MTCH2激活PI3K/Akt通路;IGF-1R的激活拯救了MTCH2的沉默效应.
结论:
- 上调的MTCH2通过PI3K/Akt路径促进BC细胞增殖和循环进展.
- MTCH2是乳腺癌治疗的潜在治疗标.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


